Wikidata

(Q63320159)

English

A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy

clinical trial

In more languages

Statements

title
A Phase 2, Open Label, Multicenter, Randomized Trial Comparing Tivozanib in Combination With mFOLFOX6 to Bevacizumab in Combination With mFOLFOX6, In Stage IV Metastatic Colorectal Cancer (mCRC) Subjects (English)
0 references
country
Australia
0 references
Austria
0 references
Belgium
0 references
Canada
0 references
Czech Republic
0 references
Finland
0 references
Hungary
0 references
Italy
0 references
Netherlands
0 references
Spain
0 references
United Kingdom
0 references
start time
December 2011
0 references
end time
September 2013
0 references
number of participants
265
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63320159&oldid=2149247184"